{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:50:13Z","timestamp":1793947813294,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Axum University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Worldwide cervical cancer is the third most common malignancy in women. It usually arises from the cervical area which is susceptible to Human Papilloma virus induced malignancy changes. In low-resource setting visual inspection with acetic acid (VIA) is an alternative sensitive cervical screening method. Therefore the aim of this study was to assess the magnitude and associated factors of VIA positive test results for Cervical Cancer screening among Eritrean refugee women aged 25\u201349\u2009years in northern Ethiopia refugee camps.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A community based cross-sectional study was conducted among 412 Eritrean refugee women aged 25\u201349\u2009years from august 10 to September 25, 2018. Study subjects were selected by simple random sampling method. Data were collected using pretested structured questioner through Face-to-face interview and cervical examination. Data were coded and entered to Epi info software version 7 and then exported to Statistical package for Social Science (SPSS) version 21 for analysis. Bivariable and multivariable logistic regression analysis was made to test the association between the independent variables and the outcome variable. <jats:italic>P<\/jats:italic>-value of less than 0.05 with 95% CI was considered to declare statistical significance.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Result<\/jats:title>\n<jats:p>In this study the magnitude of VIA positive precancerous cervical lesions was 9% (95% CI: 6.3\u201311.8%). Previous history of sexually transmitted infections (STI) [AOR (95%CI)\u2009=\u20092.84(1.07\u20137.53)] and presence of STI during cervical examination [AOR (95%CI) =3.97(1.75\u20139.00)] were found significantly associated with VIA positive precancerous cervical lesions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study the magnitude of VIA positive precancerous cervical lesions was high. Previous history of sexually transmitted infections (STI) and presence of STI during cervical examination were found associated with VIA positive precancerous cervical lesions. Efforts such as early screening for sexually transmitted disease shall be done to prevent precancerous cervical lesions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07344-9","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:02:41Z","timestamp":1599480161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25\u201349 years in North Ethiopia"],"prefix":"10.1186","volume":"20","author":[{"given":"Gebretsadik","family":"Hailemariam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailay","family":"Gebreyesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewolde","family":"Wubayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsgehana","family":"Gebregyorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidanemariam","family":"Gebrecherkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebrahtu","family":"Teweldemedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaye","family":"Kifle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"7344_CR1","volume-title":"Screening for cervical cancer : a systematic evidence review for the U. S. Preventive services task force","author":"Q Ahrq","year":"2007","unstructured":"Ahrq Q. Screening for cervical cancer : a systematic evidence review for the U. S. Preventive services task force, vol. 86; 2007."},{"issue":"9895","key":"7344_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(13)60022-7.","journal-title":"Lancet."},{"issue":"7435","key":"7344_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"632","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions : a meta-analysis update. Int J Cancer. 2007;632(7435):621\u201332.","journal-title":"Int J Cancer"},{"key":"7344_CR4","first-page":"54","volume":"4","author":"A Ntekim","year":"2012","unstructured":"Ntekim A. Cervical cancer in sub Sahara Africa. Topic Cervical Cancer Advocacy Prev. 2012;4:54\u20139.","journal-title":"Topic Cervical Cancer Advocacy Prev"},{"issue":"1","key":"7344_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","volume":"15","author":"WJ Koh","year":"2017","unstructured":"Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, et al. Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(1):92\u2013120.","journal-title":"J Natl Compr Cancer Netw"},{"key":"7344_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0020-7292(12)60023-X","volume":"2","author":"E Wiebe","year":"2012","unstructured":"Wiebe E, Denny L, Thomas G. Cancer of the cervix uteri. Int J Gynecol Obstet. 2012;2:100\u20139.","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"7344_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/rmv.416","volume":"14","author":"RL Bekkers","year":"2004","unstructured":"Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol. 2004;14(2):95\u2013105.","journal-title":"Rev Med Virol"},{"key":"7344_CR8","volume-title":"National cervical cancer prevention training package participant manual","author":"Ethiopia FMOH","year":"2015","unstructured":"Ethiopia FMOH. National cervical cancer prevention training package participant manual; 2015."},{"key":"7344_CR9","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory (GLOBOCAN). 2018. Available online: https:\/\/gco.iarc.fr. Accessed Nov 2018."},{"key":"7344_CR10","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","volume":"31","author":"FX Bosch","year":"2013","unstructured":"Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1\u201331.","journal-title":"Vaccine."},{"key":"7344_CR11","volume-title":"National Cancer Control Plan 2016\u20132020. Disease prevention control Directoraite","author":"EFMoH","year":"2015","unstructured":"EFMoH. National Cancer Control Plan 2016\u20132020. Disease prevention control Directoraite; 2015. (October):1\u201383. Available from: http:\/\/bmg.bund.de\/en.html."},{"issue":"1","key":"7344_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12905-016-0306-6","volume":"16","author":"S Finocchario-Kessler","year":"2016","unstructured":"Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16(1):29.","journal-title":"BMC Womens Health"},{"key":"7344_CR13","first-page":"302","volume-title":"Cervix cancer screening","author":"International Agency for Research on Cancer","year":"2005","unstructured":"International Agency for Research on Cancer. Cervix cancer screening. In: Cervix cancer screening; 2005. p. 302."},{"key":"7344_CR14","unstructured":"Moskosky SB. Providing Health Care to Vulnerable Populations: Reproductive Health Care for Refugees."},{"issue":"1","key":"7344_CR15","first-page":"1","volume":"50","author":"ME Hummeida","year":"2015","unstructured":"Hummeida ME, Merghani N, Burhan A. Original article safety and acceptability of cryotherapy treatment of precancerous lesions of uterine cervix using single visit method. Sudan Med J. 2015;50(1):1.","journal-title":"Sudan Med J"},{"key":"7344_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/ijc.20190","volume":"110","author":"R Sankaranarayanan","year":"2004","unstructured":"Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110:907.","journal-title":"Int J Cancer"},{"issue":"2","key":"7344_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bpobgyn.2011.11.004","volume":"26","author":"TC Wright Jr","year":"2012","unstructured":"Wright TC Jr, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):197\u2013208.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7344_CR18","first-page":"1","volume":"1","author":"K Pottie","year":"2011","unstructured":"Pottie K, Nolen A, Topp P, Torres S, Welch V, Durand N. Appendix 19 : cervical cancer : evidence review for newly arriving immigrants and refugees. Can Collab Immigrant Refugee Health (CCIRH). 2011;1:1\u201315.","journal-title":"Can Collab Immigrant Refugee Health (CCIRH)"},{"key":"7344_CR19","first-page":"96","volume":"1","author":"UNHCR","year":"2017","unstructured":"UNHCR. Essential needs. Provid Essent Needs. 2017;1:96\u2013103.","journal-title":"Provid Essent Needs"},{"key":"7344_CR20","volume-title":"Eritrea","author":"CM Profile","year":"2014","unstructured":"Profile CM, ACM T, Incidence C. Eritrea; 2014."},{"key":"7344_CR21","first-page":"2017","volume-title":"Health fact sheet","author":"UNHCR","year":"2017","unstructured":"UNHCR. Health fact sheet; 2017. p. 2017\u20138."},{"issue":"1","key":"7344_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12879-017-2186-2","volume":"17","author":"MP Bhatta","year":"2017","unstructured":"Bhatta MP, Johnson DC, Lama M, Aryal S, Lhaki P, Shrestha S. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal. BMC Infect Dis. 2017;17(1):73.","journal-title":"BMC Infect Dis"},{"key":"7344_CR23","first-page":"37","volume":"1","author":"S Pickle","year":"2014","unstructured":"Pickle S, Altshuler M, Scott KC. Cervical cancer screening outcomes in a refugee population. J Immigr Refug Stud. 2014;1:37\u201341.","journal-title":"J Immigr Refug Stud"},{"issue":"3","key":"7344_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5897\/JPHE2016.0891","volume":"9","author":"KH Misgina","year":"2017","unstructured":"Misgina KH, Belay HS, Abraha TH. Prevalence of precancerous cervical lesion and associated factors among women in north Ethiopi. J Public Health Epidemiol. 2017;9(3):46\u201350.","journal-title":"J Public Health Epidemiol"},{"key":"7344_CR25","unstructured":"World Health Organization, International Agency for Research on Cancer. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. 2012. https:\/\/apps.who.int\/iris\/handle\/10665\/75250."},{"key":"7344_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2015.22.26.7116","volume":"22","author":"JD Makuza","year":"2015","unstructured":"Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:1.","journal-title":"Pan Afr Med J"},{"issue":"2","key":"7344_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15430\/JCP.2017.22.2.103","volume":"22","author":"L Nuranna","year":"2017","unstructured":"Nuranna L, Donny NB, Purwoto G, Winarto H, Utami TW, Anggraeni TD, et al. Prevalence, age distribution, and risk factors of visual inspection with acetic acid-positive from 2007 to 2011 in Jakarta. J Cancer Prev. 2017;22(2):103.","journal-title":"J Cancer Prev"},{"key":"7344_CR28","first-page":"8","volume":"1","author":"ZM Deksissa","year":"2015","unstructured":"Deksissa ZM, Tesfamichael FA, Ferede HA. Prevalence and factors associated with VIA positive result among clients screened at family guidance Association of Ethiopia , south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross - sectional study. BMC Res Notes. 2015;1:8\u201313.","journal-title":"BMC Res Notes"},{"issue":"1","key":"7344_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-9378-8-45","volume":"8","author":"L Kafuruki","year":"2013","unstructured":"Kafuruki L, Rambau PF, Massinde A, Masalu N. Prevalence and predictors of cervical intraepithelial neoplasia among HIV infected women at Bugando medical Centre, Mwanza-Tanzania. Infect Agents Cancer. 2013;8(1):45.","journal-title":"Infect Agents Cancer"},{"key":"7344_CR30","doi-asserted-by":"publisher","first-page":"5473681","DOI":"10.1155\/2016\/5473681","volume":"2016","author":"J Izudi","year":"2016","unstructured":"Izudi J, Adrawa N, Amongin D. Precancerous cervix in human immunodeficiency virus infected women thirty years old and above in northern Uganda. J Oncol. 2016;2016:5473681.","journal-title":"J Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07344-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:14:14Z","timestamp":1630970054000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7344"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07344-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from ethical review committee of Aksum University College of health sciences and comprehensive specialized hospital (IRB 065\/2018). Written permission letter was obtained from Administration for refuge and returnee affairs shire operation and respective camp administrations. Written consent was obtained from study participants to confirm willingness for participation after explaining the objective of the study. Study participants had the right to decline any time during the data collection. After obtaining informed written consent women with positive VIA test was treated with cryotherapy and women with suspicious cervical cancer were referred to hospitals for better work up and management. Confidentiality and privacy of the study were maintained during data collection, analysis, and reporting by making the questionnaire anonymous.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This is to confirm that all authors have reviewed the submitted research article and approved the paper for submission. All authors also declare that they have no financial or non-financial competing interests. This manuscript has not been published elsewhere and is not under submission elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"858"}}